Biotechnology Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug – Regeneron Pharmaceuticals (NASDAQ:REGN) Read more
Stockmarkets US accuses Regeneron of fraudulent price reporting for eye drug Reuters via biedexmarkets.com Read more
Biotechnology Blindness-Focused LENZ Therapeutics’ Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says – LENZ Therapeutics (NASDAQ:LENZ) Read more
Biotechnology Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data Why Is Palatin Technologies Stock Soaring On Monday? – Palatin Techs (AMEX:PTN) Read more
Commodities Explainer-The nuclear power plant in the eye of the Ukraine war Reuters via biedexmarkets.com Read more
Stockmarkets Investors eye Fed rate cut, earnings as key to sustaining market rally Reuters via biedexmarkets.com Read more